Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
TreeFrog Therapeutics appoints Frederic Desdouits as CEO
TreeFrog Therapeutics announced that independent board member Frederic Desdouits had been appointed chief executive officer in conjunction with the Series B financing.
2021
TreeFrog Therapeutics closes $75 million Series B financing
TreeFrog Therapeutics announced that it had closed a $75 million (€64 million) Series B financing round, bringing total funding to date to $83 million (€70 million). The company said the funding would support deployment of its C-Stem technology for clinical-grade manufacturing, development of its cell-therapy pipeline, and the planned opening of technology hubs in Boston and Kobe.